Principal Financial Group
TARA icon

Principal Financial Group’s Protara Therapeutics TARA Stock Holding History

Principal Financial Group’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,610
Closed -$1.72M – 2249
2016
Q3 		$1.72M Sell
4,610
-31
-0.7% -$10.9K ﹤0.01% 1699
2016
Q2 		$1.49M Sell
4,641
-88
-2% -$26.3K ﹤0.01% 1706
2016
Q1 		$1.46M Sell
4,729
-32
-0.7% -$10.3K ﹤0.01% 1678
2015
Q4 		$2.95M Buy
4,761
+194
+4% +$114K ﹤0.01% 1546
2015
Q3 		$2.54M Buy
4,567
+62
+1% +$38.4K ﹤0.01% 1582
2015
Q2 		$3.22M Buy
4,505
+302
+7% +$187K ﹤0.01% 1567
2015
Q1 		$1.96M Buy
4,203
+23
+0.6% +$10.1K ﹤0.01% 1661
2014
Q4 		$1.74M Buy
+4,180
New +$1.69M ﹤0.01% 1707

Other funds holding TARA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FCI
Financial Counselors Inc Overland Park, Kansas $70.9M AUM 16.78% 1-Year Est. Return

Principal Financial Group's TARA Position: Q4 2016 in Review

Principal Financial Group sold out of Protara Therapeutics (TARA) in Q4 2016, closing a stake of 4,610 shares — an estimated $1.72M sold.

Principal Financial Group first reported a position in TARA in Q4 2014 and held it in 8 quarters. The position peaked at $3.22M in Q2 2015. 25 funds tracked by Wall St. Rank hold TARA as of Q4 2016.

  • Principal Financial Group reported no remaining Protara Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Principal Financial Group sold 4,610 Protara Therapeutics shares in Q4 2016, an estimated $1.72M.
  • Principal Financial Group first reported a position in Protara Therapeutics in Q4 2014 and held it in 8 quarters.
  • Principal Financial Group's Protara Therapeutics position peaked at $3.22M in Q2 2015.
  • 25 funds tracked by Wall St. Rank held Protara Therapeutics as of Q4 2016.

Based on Principal Financial Group's 13F filing for Q4 2016, filed 13 Feb 2017.